|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | A61K 9/12 | |
| B65D 83/00 |
| (11) | Patento numeris | 1658105 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04782101.2 |
| Europos patento paraiškos padavimo data | 2004-08-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-03-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2004/027539 |
| Data | 2004-08-25 |
| (87) | Numeris | WO 2005/023330 |
| Data | 2005-03-17 |
| (30) | Numeris | Data | Šalis |
| 499250 P | 2003-08-29 | US |
| (72) |
Miller, John F., GlaxoSmithKline, US
Sommerville, Mark L., GlaxoSmithKline, US
Schultz, Robert D., GlaxoSmithKline, US
|
| (73) |
GLAXO GROUP LIMITED,
980 Great West Road Brentford, Middlesex TW8 9GS,
GB
|
| (54) | PHARMACEUTICAL METERED DOSE INHALER AND METHODS RELATING THERETO |
| PHARMACEUTICAL METERED DOSE INHALER AND METHODS RELATING THERETO |